1. Challenging cases of eosinophilia (peripheral, bone marrow, or lymph node/tissue-based) falling into any of the following categories

Size: px
Start display at page:

Download "1. Challenging cases of eosinophilia (peripheral, bone marrow, or lymph node/tissue-based) falling into any of the following categories"

Transcription

1 Society for Hematopathology/European Association for Haematopathology 2019 Workshop Addressing the Challenges of Eosinophilia and Mastocytosis September 12-14, 2019, Phoenix, AZ Case Submission Information - see process at bottom of this page Program Committee Mayo Clinic, Scottsdale, AZ Fiona E. Craig, MD Lisa M. Rimsza, MD Mayo Clinic, Rochester, MN Rebecca L. King, MD Kaaren K. Reichard, MD Kathleen A. Meyers, BS Workshop Review Panel Fiona E. Craig, MD Tracy I. George, MD Hans Peter Horny, MD Katalin Kelemen, MD, PhD Rebecca L. King, MD Attilio Orazi, MD Leticia Quintanilla-Fend, MD Kaaren K. Reichard, MD Sa A. Wang, MD Cases to be requested include: 1. Challenging cases of eosinophilia (peripheral, bone marrow, or lymph node/tissue-based) falling into any of the following categories Reactive disorders associated with eosinophilia mimicking chronic eosinophilic leukemia, including but not limited to: o Drug, toxin, infectious, other hypersensitivity Eosinophilia associated with non-myeloid, tissue-based neoplasms or non-neoplastic lymphoproliferations (Kimura disease, B and T cell lymphomas, Hodgkin lymphoma, histiocytic neoplasms, non-hematologic malignancy) Lymphocytic variant of hypereosinophilic syndrome (LV-HES) including challenging, nodal and tissue based T cell infiltrates Idiopathic hypereosinophilic syndrome Chronic eosinophilic leukemia, NOS

2 Genetic aberrations associated with eosinophilia including but not limited to: o Myeloid/lymphoid neoplasms associated with eosinophilia and PDGRFA, PDGFRB, FGFR1, and PCM1-JAK2 o AML with inversion 16 Eosinophilia associated with other diseases aside from mastocytosis or those listed above (e.g., AML, ALL with t(5;14), myeloproliferative neoplasms, myelodysplastic syndrome, etc.) 2. Challenging cases of mastocytosis (with or without eosinophilia) including: Cutaneous mastocytosis Systemic mastocytosis (including tissue- based and nodal mast cell infiltrates) o Indolent systemic mastocytosis o Smoldering systemic mastocytosis o Systemic mastocytosis with associated hematological neoplasm o Aggressive systemic mastocytosis o Mast cell leukemia including chronic and aleukemic examples o Mast cell sarcoma Myelomastocytic leukemia Entities with proliferations of cells that may mimic mast cells (including but not limited to acute promyelocytic leukemia, basophilic leukemia) Case requirements: 1. Online submission form 2. Powerpoint file with images 3. Glass slides including completed mailing form. Materials to send*: 1) 10 H&E and 10 unstained on any tissue and bone marrow core biopsies 2) Unstained bone marrow aspirate and/or peripheral blood smear, as available (preferred) (optional) 3) If unstained BMA and PBS are not available, stained slide(s) could be submitted *Material will NOT be returned. Address for sending slides: Attn: Kathleen Meyers Mayo Clinic Department of Hematopathology RO_HI_08_ st St SW Rochester, Minnesota Case Submission Categories: 1. Chronic eosinophilic leukemia and idiopathic hypereosinophilic syndrome

3 2. Myeloid/lymphoid neoplasms with eosinophilia and recurrent genetic abnormalities (WHO 2017) 3. Myeloid neoplasms associated with eosinophilia (eg, MPN, MDS, AML, ALL; excluding those discussed above) 4. Reactive eosinophilia mimicking chronic eosinophilic leukemia 5. T-cell lymphoproliferations associated with eosinophilia (eg, lymphocytic variant of hypereosinophilic syndrome) 6. Reactive eosinophil proliferations in tissue (Kimura, lymphomas, non-heme malignancy, Langerhans cell histiocytosis etc.) 7. Systemic mastocytosis and entities that mimic mastocytosis 8. Cutaneous and other tissue-based mastocytosis/mast cell lesions Deadline for Submission: February 1, 2019 Online Case Submission Two-Step Process ASCP is managing the online case submission process for SH using a custom content submission portal into the ASCPedia pathology assets archive. Follow the rest of this step-bystep guide to create your ASCP account and upload your case. All content from SH members is accessible only by SH Program Faculty and ASCP Staff. 1. All case contributors must have an SH/ASCP account at see instructions page 3. For secure access to the ASCPedia, anyone who submits a case for the SH 2019 Workshop must have a ASCP account (not ASCP membership, just a free online account). Current SH members already have an ASCP account, as they now manage their SH membership through ASCP. New contributors who are not SH members must create an SH/ASCP account, a simple process that captures your preferred address and creates a username and password. 2. After you have created or verified your SH/ASCP account, use this link to access the SH case contribution page inside the ASCPedia see instructions page You will be asked to authenticate by entering your ASH/ASCP account username and password (see item #1), then you will be placed directly onto the SH contribute page. Fill out all required information. You cannot save a draft and edit later, so be certain to complete your submission. Keep your textual detail in a separate Word document to save for mailing and as a back-up so that you do not lose your information.

4 Questions or problems with case submission? Contact SH Workshop Manager Melissa Lord-Toof,MBA, Manager of Affiliated Organizations at or by telephone at USA

5 Creating an ASCP.org Account Step 1: Go to and click on Login

6 Creating an ASCP.org Account Step 2: Click on Create an account

7 Creating an ASCP.org Account Step 3: Fill in all required Personal information and click Continue.

8 Creating an ASCP.org Account Step 4: Fill in all required Login information and click Continue.

9 Creating an ASCP.org Account Step 5: Fill in all required Contact information and click Continue.

10 Creating an ASCP.org Account Step 6: Fill in all required Demographic information and click Continue.

11 After you have created or verified your SH/ASCP account, use this link below to access the SH case contribution page inside the ASCPedia. You will be asked to authenticate by entering your ASCP account username and password, then you will be placed directly onto the SH contribute page. SH 2019 Workshop Online Case Submission Screenshots 11

12 12

13 13

14 Questions or problems with case submission? Contact SH Workshop Manager Melissa Lord-Toof,MBA, Manager of Affiliated Organizations at or by telephone at USA 14

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D.

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D. Diagnostic Approach for Eosinophilia and Mastocytosis Curtis A. Hanson, M.D. 2014 MFMER slide-1 DISCLOSURES: Relevant Financial Relationship(s) None Off Label Usage None 2014 MFMER slide-2 Molecular Classification

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation

Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation Eosinophilia: A Diagnostic Approach and Test Utilization Strategies for Bone Marrow Evaluation American Society for Clinical Pathology 2014 Annual Meeting Presented by: Matthew T. Howard, MD Assistant

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

9/25/2017. Disclosure. I have nothing to disclose. Young S. Kim MD Dept. of Pathology

9/25/2017. Disclosure. I have nothing to disclose. Young S. Kim MD Dept. of Pathology Disclosure MAST CELLNEOPLASM I have nothing to disclose. Young S. Kim MD Dept. of Pathology 1 Objectives What is mast cell lineage? Changes in updated WHO 2016 mastocytosis Issues of Mastocytosis CD30

More information

Welcome to Master Class for Oncologists. Session 3: 9:15 AM - 10:00 AM

Welcome to Master Class for Oncologists. Session 3: 9:15 AM - 10:00 AM Welcome to Master Class for Oncologists Session 3: 9:15 AM - 10:00 AM Miami, FL December 18, 2009 Myeloproliferative Neoplasms: Bringing Order to Complexity and Achieving Optimal Outcomes Speaker: Andrew

More information

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or

More information

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular

More information

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain

More information

Introduction: The Revised (4 th Edition) World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues

Introduction: The Revised (4 th Edition) World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues Society for Hematopathology Scientific Symposium USCAP Companion Meeting, Boston, MA March 8, 2009 Boston, MA Steven H. Swerdlow and James Vardiman, Moderators Introduction: The Revised (4 th Edition)

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Practical Diagnosis of Hematologic Disorders. Vol 2 Malignant Disorders

Practical Diagnosis of Hematologic Disorders. Vol 2 Malignant Disorders 5 th ed Practical Diagnosis of Hematologic Disorders Vol 2 Malignant Disorders Vol2_FrontMatter_v03_0804 final.indd i 8/6/2009 10:00:11 PM Authors Carl R Kjeldsberg, MD Professor of Pathology, University

More information

Supervisor: Prof. Dr. P Vandenberghe Dr. C Brusselmans

Supervisor: Prof. Dr. P Vandenberghe Dr. C Brusselmans Contribution of molecular diagnosis in eosinophilia/hypereosinophilia Eosinophilia Hypereosinophilia Hypereosinophilic syndrome Immune mediated hypereosinophilia Chronic eosinophilic leukemia (NOS)/ Idiopathic

More information

Integrated Hematopathology. Morphology and FCI with IHC

Integrated Hematopathology. Morphology and FCI with IHC Integrated Hematopathology Morphology and FCI with IHC FrontMatter.indd i 9/6/2009 9:30:12 PM FrontMatter.indd ii 9/6/2009 9:30:18 PM Integrated Hematopathology Morphology and FCI with IHC Cherie H Dunphy,

More information

Hypereosinophili c syndrome

Hypereosinophili c syndrome Hypereosinophili c syndrome Eosinophilia Eosinophilia is commonly defined as an elevated percentage of eosinophils, with an absolute eosinophil count > 500 cells per cubic millimeter Secondary Primary

More information

Conditions that mimic neoplasia in the bone marrow. Kaaren K. Reichard Mayo Clinic Rochester

Conditions that mimic neoplasia in the bone marrow. Kaaren K. Reichard Mayo Clinic Rochester Conditions that mimic neoplasia in the bone marrow Kaaren K. Reichard Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Learning Objectives Multiple conditions in

More information

Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual

Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual KCR 2018 SPRING TRAINING 2018 Hematopoietic Database Updates Updates were done to the Hematopoietic Database based on the WHO Hematopoietic

More information

Systemic mastocytosis:

Systemic mastocytosis: Systemic mastocytosis: Flow cytometry and Molecular Biology Katrien Vermeulen 21 oktober 2016 Cuteanous mastocytosis Major criterion Typical skin lesions of mastocytosis associated with Darier s sign Minor

More information

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid

More information

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary

More information

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester Bone marrow morphology in reactive conditions Kaaren K. Reichard, MD Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Outline of Presentation Brief introduction General

More information

Case Report. Introduction. Mastocytosis associated with CML Hematopathology - March K. David Li 1,*, Xinjie Xu 1, and Anna P.

Case Report. Introduction. Mastocytosis associated with CML Hematopathology - March K. David Li 1,*, Xinjie Xu 1, and Anna P. Mastocytosis associated with CML Hematopathology - March 2016 Case Report Systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) involving chronic myelogenous

More information

CME/SAM. Olga Pozdnyakova, MD, PhD, 1 Svetlana Kondtratiev, MD, 1,2 Betty Li, MS, 1 Karry Charest, 1 and David M. Dorfman, MD, PhD 1.

CME/SAM. Olga Pozdnyakova, MD, PhD, 1 Svetlana Kondtratiev, MD, 1,2 Betty Li, MS, 1 Karry Charest, 1 and David M. Dorfman, MD, PhD 1. Hematopathology / New Mastocytosis Flow Cytometry Approach High-Sensitivity Flow Cytometric Analysis for the Evaluation of Systemic Mastocytosis Including the Identification of a New Flow Cytometric Criterion

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Hematology Page 1 of 8

Hematology Page 1 of 8 Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340

More information

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic

More information

LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017

LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017 Jointly provided by Mayo School of Continuous Professional Development and Mayo Continuing Nursing Education ACUTE & CHRONIC LEUKEMIAS 2017 REGISTER NOW! $75 DISCOUNT For Early Registration Expires 9/6/2017

More information

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic

More information

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms Myeloproliferative Neoplasms: A Case-Based Approach Disclosures No conflicts of interests regarding the topic being presented Adam M. Miller, MD PGY-4 Resident Physician Department of Pathology and Laboratory

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017 LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer

More information

Case #16: Diagnosis. T-Lymphoblastic lymphoma. But wait, there s more... A few weeks later the cytogenetics came back...

Case #16: Diagnosis. T-Lymphoblastic lymphoma. But wait, there s more... A few weeks later the cytogenetics came back... Case #16: Diagnosis T-Lymphoblastic lymphoma But wait, there s more... A few weeks later the cytogenetics came back... 46,XY t(8;13)(p12;q12)[12] Image courtesy of Dr. Xinyan Lu Further Studies RT-PCR

More information

Fortgeschrittene systemische Mastozytose Hintergrundinformationen zu einer seltenen Erkrankung und zur ersten zugelassenen Therapie

Fortgeschrittene systemische Mastozytose Hintergrundinformationen zu einer seltenen Erkrankung und zur ersten zugelassenen Therapie Fortgeschrittene systemische Mastozytose Hintergrundinformationen zu einer seltenen Erkrankung und zur ersten zugelassenen Therapie Georgia Metzgeroth Hämatologie und Onkologie III. Medizinische Klinik

More information

Mast Cell Disease. Daniel A. Arber, MD Stanford University, Stanford CA

Mast Cell Disease. Daniel A. Arber, MD Stanford University, Stanford CA Mast Cell Disease Daniel A. Arber, MD Stanford University, Stanford CA Mast cell disease, or mastocytosis, includes a variety of disorders that are characterized by the presence of mast cell aggregates

More information

Synonyms. Mast cell disease Mast cell proliferative disease

Synonyms. Mast cell disease Mast cell proliferative disease Mastocytosis Definition Mastocytosis is a proliferation of mast cells and their subsequent accumulation in one or more organ systems. Mast cells are derived from hematopoietic progenitors, thus mastocytosis

More information

MDS/MPN MPN MDS. Discolosures. Advances in the Diagnosis of Myeloproliferative Neoplasms. Myeloproliferative neoplasms

MDS/MPN MPN MDS. Discolosures. Advances in the Diagnosis of Myeloproliferative Neoplasms. Myeloproliferative neoplasms Discolosures Advances in the Diagnosis of Myeloproliferative Neoplasms Consulting income from Promedior, Inc. Robert P Hasserjian, MD Associate Professor Massachusetts General Hospital and Harvard Medical

More information

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk. Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this

More information

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for

More information

Case Report Chronic Eosinophilic Leukemia Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma

Case Report Chronic Eosinophilic Leukemia Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma Case Reports in Hematology Volume 2013, Article ID 458303, 4 pages http://dx.doi.org/10.1155/2013/458303 Case Report Chronic Eosinophilic Leukemia Not Otherwise Specified (NOS) in the Background of a Large

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

Myelodysplastic Syndrome Case 158

Myelodysplastic Syndrome Case 158 Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was

More information

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,

More information

2016 WHO CLASSIFICATION OF TUMOURS OF HAEMATOPOIETIC AND LYMPHOID TISSUES, 4TH ED., VOL FCDS WEBCAST SERIES OCTOBER 19, 2017

2016 WHO CLASSIFICATION OF TUMOURS OF HAEMATOPOIETIC AND LYMPHOID TISSUES, 4TH ED., VOL FCDS WEBCAST SERIES OCTOBER 19, 2017 2016 WHO CLASSIFICATION OF TUMOURS OF HAEMATOPOIETIC AND LYMPHOID TISSUES, 4TH ED., VOL 2 2017-2018 FCDS WEBCAST SERIES OCTOBER 19, 2017 STEVEN PEACE, CTR 1 CDC & Florida DOH Attribution We acknowledge

More information

WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities

WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities Robert W. McKenna, M.D. 1/2009 WHO Classification of Myeloid Neoplasms (4th Edition)--2008 Incorporates new information that

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

WHO Update to Myeloproliferative Neoplasms

WHO Update to Myeloproliferative Neoplasms WHO Update to Myeloproliferative Neoplasms Archana M Agarwal, MD, Associate Professor of Pathology University of Utah Department of Pathology/ARUP Laboratories Myeloproliferative Neoplasms The categories

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

Mastocytosis An Unusual Clonal Disorder of Bone Marrow Derived Hematopoietic Progenitor Cells

Mastocytosis An Unusual Clonal Disorder of Bone Marrow Derived Hematopoietic Progenitor Cells Mastocytosis An Unusual Clonal Disorder of Bone Marrow Derived Hematopoietic Progenitor Cells Hans-Peter Horny, MD Key Words: Mastocytosis; Mast cell; Bone marrow; KITD816V; Systemic mastocytosis with

More information

Heme 9 Myeloid neoplasms

Heme 9 Myeloid neoplasms Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

Successful flow cytometric immunophenotyping of body fluid specimens

Successful flow cytometric immunophenotyping of body fluid specimens Successful flow cytometric immunophenotyping of body fluid specimens Fiona E. Craig, MD Division of Hematopathology Mayo Clinic Arizona 2017 MFMER slide-1 Financial disclosure No conflicts 2017 MFMER slide-2

More information

Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow*

Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow* Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow* Version: Protocol Posting Date: January 2018 This protocol is NOT required for accreditation

More information

Collecting Cancer Data: Hematopoietic & Lymphoid Neoplasms

Collecting Cancer Data: Hematopoietic & Lymphoid Neoplasms Collecting Cancer Data: Hematopoietic & Lymphoid Neoplasms NAACCR 2011 2012 Webinar Series August 2, 2012 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL SH2017-0124 A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL NEGATIVE John R Goodlad 1, Pedro Martin-Cabrera 2, Catherine Cargo 2 1. Department of Pathology, NHS Greater Glasgow & Clyde, QEUH, Glasgow 2. Haematological

More information

Update on the WHO Classification of Acute Myeloid Leukemia. Kaaren K. Reichard, MD Mayo Clinic Rochester

Update on the WHO Classification of Acute Myeloid Leukemia. Kaaren K. Reichard, MD Mayo Clinic Rochester Update on the WHO Classification of Acute Myeloid Leukemia Kaaren K. Reichard, MD Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Objectives Present a practical

More information

Mast Cell Disease Case 054 Session 7

Mast Cell Disease Case 054 Session 7 Mast Cell Disease Case 054 Session 7 Rodney R. Miles, M.D., Ph.D. Lauren B. Smith, M.D. Cem Akin, M.D. Diane Roulston,, Ph.D. Charles W. Ross, M.D. Departments of Pathology and Internal Medicine University

More information

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

DETERMINATION OF A LYMPHOID PROCESS

DETERMINATION OF A LYMPHOID PROCESS Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,

More information

HEMATOLOGIC MALIGNANCIES BIOLOGY

HEMATOLOGIC MALIGNANCIES BIOLOGY HEMATOLOGIC MALIGNANCIES BIOLOGY Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic stem cell FAILURE OF TERMINAL DIFFERENTIATION

More information

MYELOPROLIFERATIVE NEOPLASMS

MYELOPROLIFERATIVE NEOPLASMS 9 : 2 MYELOPROLIFERATIVE NEOPLASMS Introduction William Dameshek in 1951 introduced the term Myeloproliferative disorders (MPD). This included polycythemia vera (PV), essential thrombocythemia (ET), primary

More information

Bone Marrow Morphology after Therapy and Stem Cell Transplantation. Arash Mohtashamian, MD Naval Medical Center, San Diego

Bone Marrow Morphology after Therapy and Stem Cell Transplantation. Arash Mohtashamian, MD Naval Medical Center, San Diego Bone Marrow Morphology after Therapy and Stem Cell Transplantation Arash Mohtashamian, MD Naval Medical Center, San Diego Objectives Bone marrow findings after myeloablative therapy. Effects of recombinant

More information

Approaching myeloid neoplasms: diagnostic algorithms

Approaching myeloid neoplasms: diagnostic algorithms Approaching myeloid neoplasms: diagnostic algorithms Alexandar Tzankov Histopathology Pathology Content Integration of clinical and laboratory data Bone marrow evaluation approaching Myeloproliferative

More information

Molecular Advances in Hematopathology

Molecular Advances in Hematopathology Molecular Advances in Hematopathology HOW MOLECULAR METHODS HAVE CHANGED MY PRACTICE Objectives Understand the importance of cytogenetic/molecular studies in hematolymphoid diseases Know some of the important

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم بسم هللا الرحمن الرحيم WBCs disorders *Slide 2: - we will focus on the disorders that are related to the # of WBCs - in children the # of lymphocyte is more than it in adults,sometimes more than neutrophils

More information

Pathology of the Hematopoietic System

Pathology of the Hematopoietic System Pathology of the Hematopoietic System Lecture 1: Introduction, Bone Marrow, and Blood Cells http://people.upei.ca/smartinson/ Shannon Martinson, April 2018 Hematopoietic system - Introduction Myeloid Tissue

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals

More information

Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Kaaren Reichard Mayo Clinic Rochester

Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Kaaren Reichard Mayo Clinic Rochester Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms Kaaren Reichard Mayo Clinic Rochester Reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Learning Objectives Present

More information

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section: Medical Policy Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Type: Medical Necessity and Investigational / Experimental Policy Specific Section:

More information

VYXEOS (daunorubicin and cytarabine)

VYXEOS (daunorubicin and cytarabine) VYXEOS (daunorubicin and cytarabine) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical

More information

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features

More information

De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child

De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child Zheng et al. Diagnostic Pathology (2018) 13:14 https://doi.org/10.1186/s13000-018-0691-2 CASE REPORT Open Access De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report

More information

The College of American Pathologists offers these protocols

The College of American Pathologists offers these protocols Strategies for Laboratory and Patient Management Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms of the Bone Marrow A Basis for Checklists LoAnn C. Peterson, MD; Steven

More information

How Personalized Medicine is Changing the Biopharmaceutical Marketplace

How Personalized Medicine is Changing the Biopharmaceutical Marketplace How Personalized Medicine is Changing the Biopharmaceutical Marketplace Marc Chioda, PharmD Associate Medical Director, Pfizer Oncology. Presentation to the Cancer Action Coalition of Virginia January

More information

APPENDIX I. Free-Standing Radiation Therapy Centers Cancer Case Identification Program

APPENDIX I. Free-Standing Radiation Therapy Centers Cancer Case Identification Program APPENDIX I Free-Standing Radiation Therapy Centers Cancer Case Identification Program I-1 Sending Radiation Therapy data to FCDS Beginning January 1, 2003, all Florida Radiation Therapy Centers must send

More information

Presenter Disclosure Information

Presenter Disclosure Information Welcome to Master Class for Oncologists Session 3: 2: PM 3:3 PM Pasadena, CA May 1, 21 Myeloproliferative Neoplasms 21 Speaker: Ayalew Tefferi Mayo Clinic, Rochester, MN Presenter Disclosure Information

More information

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile Myelomonocytic Leukemia (JMML) Juvenile Myelomonocytic Leukemia (JMML) JMML: Definition Monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages Erythroid and megakaryocytic

More information

Histiocytic Neoplasms of the Dog and Cat

Histiocytic Neoplasms of the Dog and Cat Histiocytic Neoplasms of the Dog and Cat V.E. Valli DVM Histiocytic and Dendritic Cell Populations Both lineages are bone marrow derived. Macrophages are part of the innate immune system that are phagocytic

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

MYELODYSPLASTIC AND MYELOPROLIFERATIVE

MYELODYSPLASTIC AND MYELOPROLIFERATIVE MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISORDERS Pediatric Hemato-Oncology Division Medical Faculty University of Sumatera Utara 1 MYELODYSPLASIA SYNDROME A group of disorder defect in hematopoetic cell

More information

Test Definition: LCMS Leukemia/Lymphoma Immunophenotyping by Flow Cytometry

Test Definition: LCMS Leukemia/Lymphoma Immunophenotyping by Flow Cytometry Reporting Title: Leukemia/Lymphoma, Phenotype Performing Location: Rochester Advisory Information: This test is appropriate for hematopoietic specimens only. If your specimen is a solid tissue, order LLPT

More information

Protocol for the Examination of Hematologic Malignancies in Bone Marrow

Protocol for the Examination of Hematologic Malignancies in Bone Marrow Protocol for the Examination of Hematologic Malignancies in Bone Marrow Version: Bone Marrow 4.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of this protocol is recommended

More information

Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)

Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using

More information

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow 74y old Female with chronic elevation of Platelet count August 18, 2005 Faizi Ali, MD Hematopathology Fellow Clinical History Patient is a 74y old otherwise healthy Caucasian female with no major complaint

More information

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow Quality ID #67 (NQF 0377): Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow National Quality Strategy Domain: Effective Clinical Care

More information

Cost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic

Cost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic Cost-Effective Strategies in the Workup of Hematologic Neoplasm Karl S. Theil, Claudiu V. Cotta Cleveland Clinic In the past 12 months, we have not had a significant financial interest or other relationship

More information

Case Presentation. Attilio Orazi, MD

Case Presentation. Attilio Orazi, MD Case Presentation Attilio Orazi, MD Weill Cornell Medical College/ NYP Hospital Department of Pathology and Laboratory Medicine New York, NY United States History 60 year old man presented with anemia

More information

Peripheral Blood Smear: Diagnostic Clues and Algorithms

Peripheral Blood Smear: Diagnostic Clues and Algorithms Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

This section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard

This section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard Data Dictionary Case Administration This section allows identifying the facility, this information is important for data quality follow up Facility Name This identifier is needed to evaluate This data

More information

When/How to Update a ClinicalTrials.gov Record

When/How to Update a ClinicalTrials.gov Record When/How to Update a ClinicalTrials.gov Record When to Update a ClinicalTrials.gov Record? 1) Within 30 days of a change in: Locations Recruitment Status at any participating site (Opened, Suspended, Closed)

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Megan S. Lim MD PhD University of Pennsylvania October 8, 2018 Objectives To understand how the trend toward less invasive lymph

More information